Haemonetics Debt to Equity Ratio 2012-2025 | HAE
Current and historical debt to equity ratio values for Haemonetics (HAE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Haemonetics debt/equity for the three months ending September 30, 2025 was 1.08.
| Haemonetics Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $1.59B | $0.85B | 1.88 |
| 2025-06-30 | $1.58B | $0.88B | 1.79 |
| 2025-03-31 | $1.63B | $0.82B | 1.99 |
| 2024-12-31 | $1.62B | $0.91B | 1.79 |
| 2024-09-30 | $1.65B | $0.88B | 1.87 |
| 2024-06-30 | $1.64B | $0.91B | 1.81 |
| 2024-03-31 | $1.24B | $0.96B | 1.29 |
| 2023-12-31 | $1.26B | $0.94B | 1.33 |
| 2023-09-30 | $1.12B | $0.89B | 1.25 |
| 2023-06-30 | $1.10B | $0.87B | 1.27 |
| 2023-03-31 | $1.12B | $0.82B | 1.37 |
| 2022-12-31 | $1.10B | $0.78B | 1.42 |
| 2022-09-30 | $1.14B | $0.73B | 1.56 |
| 2022-06-30 | $1.05B | $0.77B | 1.36 |
| 2022-03-31 | $1.11B | $0.75B | 1.48 |
| 2021-12-31 | $1.10B | $0.73B | 1.51 |
| 2021-09-30 | $1.10B | $0.70B | 1.58 |
| 2021-06-30 | $1.12B | $0.68B | 1.65 |
| 2021-03-31 | $1.09B | $0.73B | 1.49 |
| 2020-12-31 | $0.60B | $0.72B | 0.83 |
| 2020-09-30 | $0.75B | $0.67B | 1.12 |
| 2020-06-30 | $0.83B | $0.61B | 1.36 |
| 2020-03-31 | $0.68B | $0.59B | 1.16 |
| 2019-12-31 | $0.66B | $0.58B | 1.15 |
| 2019-09-30 | $0.61B | $0.58B | 1.04 |
| 2019-06-30 | $0.67B | $0.59B | 1.13 |
| 2019-03-31 | $0.61B | $0.67B | 0.91 |
| 2018-12-31 | $0.59B | $0.64B | 0.91 |
| 2018-09-30 | $0.56B | $0.70B | 0.81 |
| 2018-06-30 | $0.57B | $0.67B | 0.84 |
| 2018-03-31 | $0.49B | $0.75B | 0.64 |
| 2017-12-31 | $0.49B | $0.82B | 0.59 |
| 2017-09-30 | $0.47B | $0.80B | 0.59 |
| 2017-06-30 | $0.48B | $0.77B | 0.62 |
| 2017-03-31 | $0.50B | $0.74B | 0.68 |
| 2016-12-31 | $0.54B | $0.77B | 0.70 |
| 2016-09-30 | $0.59B | $0.75B | 0.78 |
| 2016-06-30 | $0.60B | $0.72B | 0.84 |
| 2016-03-31 | $0.60B | $0.72B | 0.83 |
| 2015-12-31 | $0.62B | $0.72B | 0.86 |
| 2015-09-30 | $0.64B | $0.78B | 0.83 |
| 2015-06-30 | $0.64B | $0.79B | 0.80 |
| 2015-03-31 | $0.66B | $0.83B | 0.80 |
| 2014-12-31 | $0.64B | $0.83B | 0.77 |
| 2014-09-30 | $0.65B | $0.82B | 0.80 |
| 2014-06-30 | $0.66B | $0.82B | 0.81 |
| 2014-03-31 | $0.68B | $0.84B | 0.81 |
| 2013-12-31 | $0.66B | $0.83B | 0.80 |
| 2013-09-30 | $0.69B | $0.80B | 0.86 |
| 2013-06-30 | $0.71B | $0.77B | 0.91 |
| 2013-03-31 | $0.69B | $0.77B | 0.90 |
| 2012-12-31 | $0.70B | $0.78B | 0.89 |
| 2012-09-30 | $0.68B | $0.77B | 0.88 |
| 2012-06-30 | $0.17B | $0.76B | 0.23 |
| 2012-03-31 | $0.18B | $0.73B | 0.24 |
| 2011-12-31 | $0.14B | $0.71B | 0.20 |
| 2011-09-30 | $0.15B | $0.68B | 0.21 |
| 2011-06-30 | $0.14B | $0.71B | 0.20 |
| 2011-03-31 | $0.15B | $0.69B | 0.21 |
| 2010-12-31 | $0.14B | $0.65B | 0.21 |
| 2010-09-30 | $0.14B | $0.59B | 0.24 |
| 2010-06-30 | $0.13B | $0.57B | 0.24 |
| 2010-03-31 | $0.17B | $0.59B | 0.28 |
| 2009-12-31 | $0.13B | $0.57B | 0.23 |
| 2009-09-30 | $0.14B | $0.58B | 0.23 |
| 2009-06-30 | $0.13B | $0.56B | 0.23 |
| 2009-03-31 | $0.11B | $0.54B | 0.20 |
| 2008-12-31 | $0.11B | $0.52B | 0.21 |
| 2008-09-30 | $0.10B | $0.50B | 0.21 |
| 2008-06-30 | $0.11B | $0.49B | 0.23 |
| 2008-03-31 | $0.12B | $0.49B | 0.23 |
| 2007-12-31 | $0.09B | $0.47B | 0.19 |
| 2007-09-30 | $0.10B | $0.45B | 0.23 |
| 2007-06-30 | $0.10B | $0.48B | 0.21 |
| 2007-03-31 | $0.09B | $0.48B | 0.19 |
| 2006-12-31 | $0.10B | $0.45B | 0.21 |
| 2006-09-30 | $0.10B | $0.46B | 0.23 |
| 2006-06-30 | $0.11B | $0.46B | 0.23 |
| 2006-03-31 | $0.11B | $0.44B | 0.24 |
| 2005-12-31 | $0.10B | $0.42B | 0.25 |
| 2005-09-30 | $0.11B | $0.39B | 0.29 |
| 2005-06-30 | $0.11B | $0.37B | 0.30 |
| 2005-03-31 | $0.11B | $0.36B | 0.32 |
| 2004-12-31 | $0.12B | $0.34B | 0.36 |
| 2004-09-30 | $0.12B | $0.31B | 0.38 |
| 2004-06-30 | $0.12B | $0.30B | 0.41 |
| 2004-03-31 | $0.13B | $0.28B | 0.46 |
| 2003-12-31 | $0.13B | $0.26B | 0.50 |
| 2003-09-30 | $0.14B | $0.24B | 0.56 |
| 2003-06-30 | $0.13B | $0.23B | 0.58 |
| 2003-03-31 | $0.14B | $0.22B | 0.61 |
| 2002-12-31 | $0.15B | $0.22B | 0.65 |
| 2002-09-30 | $0.14B | $0.21B | 0.67 |
| 2002-06-30 | $0.14B | $0.22B | 0.62 |
| 2002-03-31 | $0.13B | $0.24B | 0.54 |
| 2001-12-31 | $0.13B | $0.26B | 0.52 |
| 2001-09-30 | $0.15B | $0.25B | 0.59 |
| 2001-06-30 | $0.13B | $0.24B | 0.57 |
| 2001-03-31 | $0.13B | $0.22B | 0.60 |
| 2000-12-31 | $0.14B | $0.20B | 0.70 |
| 2000-09-30 | $0.13B | $0.19B | 0.70 |
| 2000-06-30 | $0.13B | $0.21B | 0.62 |
| 2000-03-31 | $0.14B | $0.21B | 0.69 |
| 1999-12-31 | $0.15B | $0.21B | 0.71 |
| 1999-09-30 | $0.13B | $0.21B | 0.62 |
| 1999-06-30 | $0.13B | $0.22B | 0.58 |
| 1999-03-31 | $0.13B | $0.22B | 0.61 |
| 1998-12-31 | $0.13B | $0.22B | 0.59 |
| 1998-09-30 | $0.13B | $0.21B | 0.63 |
| 1998-06-30 | $0.13B | $0.20B | 0.66 |
| 1998-03-31 | $0.14B | $0.20B | 0.73 |
| 1997-12-31 | $0.14B | $0.22B | 0.64 |
| 1997-09-30 | $0.14B | $0.23B | 0.59 |
| 1997-06-30 | $0.12B | $0.23B | 0.52 |
| 1997-03-31 | $0.10B | $0.23B | 0.44 |
| 1996-12-31 | $0.08B | $0.23B | 0.34 |
| 1996-09-30 | $0.07B | $0.24B | 0.31 |
| 1996-06-30 | $0.07B | $0.23B | 0.31 |
| 1996-03-31 | $0.07B | $0.22B | 0.33 |
| 1995-12-31 | $0.07B | $0.22B | 0.34 |
| 1995-09-30 | $0.08B | $0.21B | 0.41 |
| 1995-06-30 | $0.09B | $0.20B | 0.44 |
| 1995-03-31 | $0.09B | $0.19B | 0.45 |
| 1994-12-31 | $0.07B | $0.19B | 0.40 |
| 1994-09-30 | $0.07B | $0.18B | 0.40 |
| 1994-06-30 | $0.06B | $0.17B | 0.38 |
| 1994-03-31 | $0.07B | $0.16B | 0.44 |
| 1993-12-31 | $0.06B | $0.15B | 0.38 |
| 1993-09-30 | $0.06B | $0.14B | 0.41 |
| 1993-06-30 | $0.05B | $0.13B | 0.38 |
| 1993-03-31 | $0.06B | $0.13B | 0.48 |
| 1992-12-31 | $0.05B | $0.12B | 0.40 |
| 1992-09-30 | $0.05B | $0.11B | 0.46 |
| 1992-06-30 | $0.05B | $0.10B | 0.52 |
| 1992-03-31 | $0.05B | $0.09B | 0.60 |
| 1991-12-31 | $0.06B | $0.08B | 0.75 |
| 1991-09-30 | $0.05B | $0.08B | 0.71 |
| 1991-06-30 | $0.05B | $0.07B | 0.63 |
| 1991-03-31 | $0.05B | $0.07B | 0.74 |
| 1990-03-31 | $0.06B | $0.05B | 1.05 |
| 1989-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.690B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $216.142B | 24.91 |
| EssilorLuxottica (ESLOY) | France | $149.893B | 0.00 |
| Boston Scientific (BSX) | United States | $139.557B | 31.91 |
| Stryker (SYK) | United States | $136.074B | 27.02 |
| Medtronic (MDT) | Ireland | $123.612B | 17.13 |
| Medline (MDLN) | United States | $56.293B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.245B | 0.00 |
| Agilent Technologies (A) | United States | $41.482B | 26.22 |
| GE HealthCare Technologies (GEHC) | United States | $38.615B | 18.47 |
| ResMed (RMD) | United States | $37.167B | 25.72 |
| Koninklijke Philips (PHG) | Netherlands | $28.531B | 18.64 |
| Terumo (TRUMY) | Japan | $21.128B | 23.78 |
| Insulet (PODD) | United States | $19.568B | 60.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.507B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.553B | 0.00 |
| Baxter (BAX) | United States | $10.101B | 8.15 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.690B | 31.25 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| BillionToOne (BLLN) | United States | $4.433B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.366B | 13.30 |
| Envista Holdings (NVST) | United States | $3.820B | 21.92 |
| ICU Medical (ICUI) | United States | $3.661B | 23.24 |
| Prestige Consumer Healthcare (PBH) | United States | $3.111B | 14.19 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.262B | 14.54 |
| Perrigo (PRGO) | Ireland | $2.073B | 5.19 |
| Neogen (NEOG) | United States | $1.999B | 43.76 |
| LeMaitre Vascular (LMAT) | United States | $1.891B | 38.06 |
| AtriCure (ATRC) | United States | $1.810B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.784B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.742B | 76.36 |
| Phibro Animal Health (PAHC) | United States | $1.640B | 16.38 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.515B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.286B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.151B | 341.43 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.054B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.028B | 0.00 |
| Omeros (OMER) | United States | $0.895B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.02 |
| Valneva SE (VALN) | France | $0.864B | 0.00 |
| CeriBell (CBLL) | United States | $0.845B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.564B | 15.30 |
| Cerus (CERS) | United States | $0.484B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.476B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.472B | 0.00 |
| Brainsway (BWAY) | Israel | $0.467B | 79.45 |
| Canopy Growth (CGC) | Canada | $0.461B | 0.00 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Evolus (EOLS) | United States | $0.371B | 0.00 |
| Quanterix (QTRX) | United States | $0.334B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 21.97 |
| Sanuwave Health (SNWV) | United States | $0.245B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| TerrAscend (TSNDF) | Canada | $0.236B | 0.00 |
| High Tide (HITI) | Canada | $0.235B | 0.00 |
| Organigram Global (OGI) | Canada | $0.228B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.211B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.194B | 1.95 |
| Utah Medical Products (UTMD) | United States | $0.188B | 16.54 |
| OraSure Technologies (OSUR) | United States | $0.187B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.76 |
| Biote (BTMD) | United States | $0.111B | 4.86 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Sharps Technology (STSS) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.58 |
| Nephros (NEPH) | United States | $0.047B | 34.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Jin Medical (ZJYL) | China | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.57 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |